< Back
I.V solution & Oral solution
Strength and Package description:
20 mg/ml - cont w/ 10 vials of 1 ml and w/ 10 vials of 3 ml
Therapeutic category: NEONATOLOGY
Therapeutic action: indicated for the treatment of apnea of prematurity
Intratracheal Suspension
Strength and Package description:
30 mg/ml - vial w/ 90 mg
30 mg/ml - vial w/ 120 mg
25 mg/ml - vial w/ 200 mg
30 mg/ml - vial w/ 240 mg
Therapeutic category: NEONATOLOGY
Therapeutic action: For Respiratory Distress Syndrome
CAFEÍNA CITRATO RICHET
Caffeine CitrateI.V solution & Oral solution
Strength and Package description:
20 mg/ml - cont w/ 10 vials of 1 ml and w/ 10 vials of 3 ml
Therapeutic category: NEONATOLOGY
Therapeutic action: indicated for the treatment of apnea of prematurity
SURFACTANTE B RICHET
Pulmonary surfactantIntratracheal Suspension
Strength and Package description:
30 mg/ml - vial w/ 90 mg
30 mg/ml - vial w/ 120 mg
25 mg/ml - vial w/ 200 mg
30 mg/ml - vial w/ 240 mg
Therapeutic category: NEONATOLOGY
Therapeutic action: For Respiratory Distress Syndrome
